Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers by Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisutthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun

Get full text